NCI Selects Five Teams of Researchers to Expand Discovery of Predictive Biomarkers for Immunotherapy

Translating Early Research to Adapt CAR T-Cell Therapy to Solid Tumors

Passing of The Baton—On the Death of Patient Research Advocates

TERAVOLT: Increased Risk of Morbidity for Patients with Lung Cancer and COVID-19 Drives Research Collaboration

Cultural Context Largely Absent in Advanced Care Planning Research, Guidelines

Treatment of Immunotherapy-Related Dermatologic Toxicities: An Interview with Dr. Mario Lacouture